Skip to main content

Part of the book series: Developments in Medical Virology ((DIMV,volume 4))

Abstract

All interferons consistently cause a variety of symptoms and signs in man which are interpreted as “toxic” effects because they are unpleasant, but may reflect the normal pathophysiologic effects of high levels of endogenous interferon produced acutely during virus infections or chronically during active autoimmune processes. Many of the effects appear to be non-specific and are probably in part mediated by inflammatory prostaglandin synthesis. Toxic effects may be augmented by impurities in interferons derived from any source. They may be reduced by giving prostaglandin antagonists or steroids or by giving interferons in the evening. Both subjectively and objectively, acute febrile responses and associated symptoms are often reduced with repeated dosing, but tend to be replaced by chronic fatigue and malaise. Idiosyncratic responses such as glomerulonephritis, thrombocytopenia or thyroid disease may involve autoimmune processes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Falcoff, E., Falcoff, R., Fournier, F. and Chany, C. Ann. Inst. Pasteur 111: 562–584, 1966.

    CAS  Google Scholar 

  2. Strander, H., Cantell, K., Carlstrom, G. and Jakobsson, P.J. Natn. Cancer Inst. 51: 733–742, 1973.

    CAS  Google Scholar 

  3. Ingimarrson, S., Cantell, K. and Strander, H. J. Infect. Dis. 140: 560–563, 1979.

    Article  Google Scholar 

  4. Scott, G., Stewart, W.E.11, Tyrrell, D.A.J., Cantell, K. and Edy, V. J. Interferon Res. 1: 79–86, 1980.

    Article  PubMed  CAS  Google Scholar 

  5. Priestman, T. J. Lancet 2: 113–118, 1980.

    Article  CAS  Google Scholar 

  6. Scott, G.M., Secher, D.S., Flowers, D., Bate, J., Cantell, K. and Tyrrell, D.A.J. Br. Med. J. 282: 1345–1348, 1981.

    Article  CAS  Google Scholar 

  7. Spiegel, R.J. Semin. Oncol. 13: 89–101, 1986.

    PubMed  CAS  Google Scholar 

  8. Jones, G.J. and Itri, L.M. Cancer 57: 1709–1715, 1986.

    Article  PubMed  CAS  Google Scholar 

  9. Sama, G., Pertcheck, M., Figlin, R. and Ardalan, B. Cancer Treat. Rep. 70: 1365–1372, 1986.

    Google Scholar 

  10. Kurzrock, R., Quesada, J.R., Rosenblum M.G., Sherwin, S.A. and Gutterman, J.U. Cancer Treat. Rep. 70: 1357–1364, 1986.

    PubMed  CAS  Google Scholar 

  11. Heron, I. and Berg, K. Nature 274: 508–510, 1978.

    Article  PubMed  CAS  Google Scholar 

  12. Stringfellow, D.A. Science 201: 376–378, 1978.

    Article  PubMed  CAS  Google Scholar 

  13. Scott, G.M., Ward, R.J., Wright, D.J., Robinson, J.A., Onwubalili, J.K. and Gauci, C.L. Antimicrob. Agents Chemother. 23: 589–592, 1983.

    PubMed  CAS  Google Scholar 

  14. Jacobs, L., Salazar, A.M., Herndon, R., Reese, P.A., Freeman, A., Josefowicz, R., Cuetter, A., Husain, F., Smith, W.A., Ekes, R. and O’Malley, J.A. Lancet 2: 1411–1413, 1986.

    Article  PubMed  CAS  Google Scholar 

  15. Hawkins, M.J., Borden, E.S. and Edwards B.S. J. Clin. Oncol. 2: 221–226, 1984.

    PubMed  CAS  Google Scholar 

  16. Oldham, R.R. Science 219: 902, 1982.

    Article  Google Scholar 

  17. Blalock, J.E. and Stanton G.J. Nature 283: 406, 1980

    Article  PubMed  CAS  Google Scholar 

  18. Rohatiner, A.Z.S., Prior, P.F., Burton, A.C., Smith, A.T., Balkwill, F.R. and Lister, T.A. Br. J. Cancer 47: 419–422, 1983

    Article  PubMed  CAS  Google Scholar 

  19. Yaron, M., Yaron, I., Gurari-Rotman, D., Revel, M., Lindner, H. and Zor, V. Nature 267: 457–459, 1977.

    Article  PubMed  CAS  Google Scholar 

  20. Fuse, A., Mahmud, I., and Kuwata, T. Cancer Res. 42: 3209–3214, 1982.

    PubMed  CAS  Google Scholar 

  21. Dinarello, CA., Bernheim, H.A., Duff, G.W., Hung, V.L., Nagabushan, T.C., Hamilton, N.C. and Coceani, F. J. Clin. Invest. 74: 906–913, 1984.

    Article  PubMed  CAS  Google Scholar 

  22. Lucero, M.A., Magdelenat, H., Fridman, W.H., Pouillart, P., Billiau, A., Cantell, K. and Falcoff, E. Eur. J. Cancer Clin. Oncol. 18: 243–251, 1982.

    Article  PubMed  CAS  Google Scholar 

  23. Abrams, P.G., McClamrock, E. and Foon, K.A. N. Engl. J. Med. 312: 443–444, 1985.

    Article  PubMed  CAS  Google Scholar 

  24. Merigan, T.C., Sikora, K., Breeden, J., Levy, R., and Rosenberg, S.A. N. Engl. J. Med. 299: 1449–1453, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Finter, N.B., Woodroffe, J. and Priestman, T. Nature 298: 301, 1982.

    Article  PubMed  CAS  Google Scholar 

  26. Feldberg, W. and Scott, G. J. Physiol. 355:28P, 1984

    Google Scholar 

  27. Calvet, M-C. and Gresser, I. Nature 278:558–560, 1979

    Article  PubMed  CAS  Google Scholar 

  28. Elfenbeim, D.S., Murphy, P.A., Chesney, P.J., Seto, D.S. and Carver, D.H. J. gen. Virol. 42: 185–187, 1979

    Article  Google Scholar 

  29. Hayden, F.G., Mills, S.E. and Johns, M.E. J. Infect. Dis. 148: 914–921, 1983.

    Article  PubMed  CAS  Google Scholar 

  30. Hayden, F.G., Innes, D.J., Mills, S.E. and Levine, P.A. In: The Biology of the Interferon System 1986 (Eds. K. Cantell and H. Schellekens), Martinus Nijhoff, Dordrecht, 1987, pp.449–456.

    Google Scholar 

  31. Mirro, J., Kalwinsky, D., Whisnant, J., Weck, P. Chesney, C. and Murphy, S. Cancer Treat. Rep. 69: 315–317, 1985.

    PubMed  Google Scholar 

  32. Broxmeyer, H., Lu, L., Platzer, E., Feit. C., Juliano L. and Rubin, Y. J. Immunol. 131: 1300–1313, 1983

    PubMed  CAS  Google Scholar 

  33. Kataoka, T., Ohhashi, F., Sukurai, Y., and Ida, N. Cancer Chemother. Pharmacol. 9: 75–80, 1982

    Article  PubMed  CAS  Google Scholar 

  34. Mannering, G.J., Renton, K.W., El Azhary, R., and Deloria L.B. Ann. N.Y. Acad. Sci. 350: 314–331, 1980.

    Article  PubMed  CAS  Google Scholar 

  35. Gresser, I., Tovey, M.G., Bandu, M.T., Maury, C. and Brouty-Boye, D. Nature 258: 76–78, 1975.

    Article  PubMed  CAS  Google Scholar 

  36. Kauppila, A., Cantell, K., Janne, O., Kokko, E. and Vikho, R. Int. J. Cancer 29: 291–294, 1982.

    Article  PubMed  CAS  Google Scholar 

  37. Cantell, K., Enholm, C., Mattila, K. and Kostianen, E. N. Engl. J. Red. 302: 1032–1033, 1980

    CAS  Google Scholar 

  38. Smedley, H., Katrak, M., Sikora, K. and Wheeler, T. Br. Med. J. 286: 262–264, 1983.34.

    Article  CAS  Google Scholar 

  39. Rohatiner A.Z., Balkwill, F.R., Griffin, D.B., Malpas, J.S. and Lister, T.A. Cancer Chemother. Pharmacol. 9: 97–102, 1982.

    Article  PubMed  CAS  Google Scholar 

  40. Cheeseman, S.H., Rubin, R., Stewart, J., Tolkoff-Rubin, N., Cosimi, A., Cantell, K., Gilbert, J., Winkle, S., Herrin, J., Black, P., Russell, P. and Hirsch, M. N. Engl. J. Med. 300: 1345–1349, 1979.

    Article  PubMed  CAS  Google Scholar 

  41. Kramer, P., Ten Kate, F., Bijnen, A. and Weimar, W. Lancet 1: 989–990, 1984.

    Article  PubMed  CAS  Google Scholar 

  42. Averbuch, S.D., Austin, H.A., Sherwin, S.A., Antonovych, T., Bunn, P.A. and Longo, D.L. N. Engl. J. Med. 300:32–35, 1984.

    Article  Google Scholar 

  43. Herrman, J. and Gabriel, F. N. Engl. J. Med. 316: 112–113, 1987

    Article  PubMed  CAS  Google Scholar 

  44. Fentiman, I.S., Thomas, B.S., Balkwill, F.R., Rubens, R.D. and Hayward, J.L. Lancet 1: 1166, 1985.

    Article  PubMed  CAS  Google Scholar 

  45. Burman, P., Totterman, T.H., Oberg, K. and Karlsson, F.A. J. Clin. Endocrinol. Metab. 63: 1086–1090, 1986.

    Article  PubMed  CAS  Google Scholar 

  46. Bevan, P.C. Lancet 2: 561, 1985.

    Article  PubMed  CAS  Google Scholar 

  47. Sangster, G., Kaye, S.B., Caiman, K.C. and Toy, J.L. Eur. J. Clin. Oncol. 19: 1647–1649, 1983.

    Article  CAS  Google Scholar 

  48. Mogensen, K.E., Daubas, P., Gresser, I., Sereni, D. and Varet, B. Lancet 2: 1227–1228, 1981.

    Article  PubMed  CAS  Google Scholar 

  49. Vallbracht, A., Treuner, J., Manncke, K.H. and Niethammer, D. J. Interferon Res. 2: 107–110, 1982.

    Article  PubMed  CAS  Google Scholar 

  50. Krown, S.E., Real, F., Cunningham-Rundles, S., Mysowski, P.L., Koziner, B., Fein, S., Mittleman, A., Oettgen, H.F. and Safai, B. N. Engl. J. Med. 308: 1071–1076, 1983.

    Article  PubMed  CAS  Google Scholar 

  51. Quesada, J.R. and Gutterman, J.U. J. Natl. Cancer Inst. 70: 1041–1046, 1983.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Scott, G.M.S. (1988). Toxic Effects. In: Revel, M. (eds) Clinical Aspects of Interferons. Developments in Medical Virology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1737-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1737-1_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8977-7

  • Online ISBN: 978-1-4613-1737-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics